Medartis cancels convertible bond despite sweetening terms
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
EquityEquity-Linked

Medartis cancels convertible bond despite sweetening terms

Victoria Thiele
April 08, 2022 05:58 PM
A skull with titanium plates of Medartis, a Swiss producer of metal implants for the surgical management of fractures, is seen during a news conference to present the planned IPO, in Zurich, Switzerland March 12, 2018. REUTERS/Moritz Hager

'Aggressive' pricing fails to attract investors

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity-LinkedSwitzerlandHealth and Biotech
VT
Victoria Thiele
Senior Reporter - CLOs
Contact
Gift this article